New Perspectives in the Treatment of Cushing's Syndrome

E-ISSN： 1875-5917|4|4|335-342

ISSN： 1568-0088

Source： Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol.4, Iss.4, 2004-12, pp. : 335-342

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drugs in the medical treatment of Cushing's syndrome

By Schteingart David E

Expert Opinion on Emerging Drugs, Vol. 14, Iss. 4, 2009-12 ,pp. : 661-671

Informa Healthcare

Access to resources Recommend Favorite

Cushing's syndrome

By Newell-Price John

Clinical Medicine, Vol. 8, Iss. 2, 2008-04 ,pp. : 204-208

Royal College Of Physicians

Access to resources Recommend Favorite

Psychiatric Disorders Associated with Cushing's Syndrome: Epidemiology, Pathophysiology and Treatment

By Sonino N.

CNS Drugs, Vol. 15, Iss. 5, 2001-01 ,pp. : 361-373

Adis International

Access to resources Recommend Favorite

Tissue-specific Cushing's syndrome uncovers a new target in treating the metabolic syndrome – 11β-hydroxysteroid dehydrogenase type 1

By Stewart Paul M

Clinical Medicine, Vol. 5, Iss. 2, 2005-03 ,pp. : 142-146

Royal College Of Physicians

Access to resources Recommend Favorite

Pasireotide for the treatment of Cushing's disease

By Arnaldi Giorgio Boscaro Marco

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 7, 2010-07 ,pp. : 889-898

Informa Healthcare

Access to resources Recommend Favorite